LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

Search

Avita Therapeutics Inc

Închisă

5.52 -4.5

Rezumat

Modificarea prețului

24h

Curent

Minim

5.3

Maxim

5.76

Indicatori cheie

By Trading Economics

Venit

-2.3M

-14M

Vânzări

108K

19M

EPS

-0.826

Marjă de profit

-74.857

Angajați

260

EBITDA

-9.9M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+161.55% upside

Dividende

By Dow Jones

Următoarele câștiguri

7 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-82M

162M

Deschiderea anterioară

10.02

Închiderea anterioară

5.52

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

Avita Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

12 iun. 2025, 20:41 UTC

Câștiguri

Adobe Raises Outlook After 2Q Sales Beat

12 iun. 2025, 23:50 UTC

Câștiguri

Adobe Keeps Pivoting as AI Transforms Customer Needs -- Update

12 iun. 2025, 23:50 UTC

Câștiguri

Adobe Customer Demand Shifting Toward Idea Generation, CFO Says

12 iun. 2025, 23:50 UTC

Câștiguri

Adobe FireFly Products Drove Revenue Beat in 2Q, CFO Says

12 iun. 2025, 23:48 UTC

Market Talk

Gold Steady Amid Geopolitical Risks -- Market Talk

12 iun. 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12 iun. 2025, 23:45 UTC

Market Talk

Nikkei May Trade Rangebound Amid Tariff Uncertainty -- Market Talk

12 iun. 2025, 21:26 UTC

Câștiguri

Friedman Industries 4Q Sales $129.2M >FRD

12 iun. 2025, 21:25 UTC

Câștiguri

Friedman Industries 4Q EPS 76c >FRD

12 iun. 2025, 21:11 UTC

Câștiguri

Adobe Beat Estimates and Raises Revenue Guidance -- Barrons.com

12 iun. 2025, 20:50 UTC

Market Talk
Câștiguri

Tech, Media & Telecom Roundup: Market Talk

12 iun. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 iun. 2025, 20:31 UTC

Câștiguri

Adobe Beat Estimates and Raises Revenue Guidance -- Barrons.com

12 iun. 2025, 20:30 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Chime IPO: Stock Soars in Nasdaq Debut, Valuing It at Nearly $14 Billion -- Barrons.com

12 iun. 2025, 20:15 UTC

Câștiguri

Adobe Sees FY25 Rev $23.5B-$23.6B >ADBE

12 iun. 2025, 20:15 UTC

Câștiguri

Adobe Sees 3Q Rev $5.88B-$5.93B >ADBE

12 iun. 2025, 20:14 UTC

Câștiguri

Adobe Stock Pops as Earnings Beat Estimates -- Barrons.com

12 iun. 2025, 20:07 UTC

Câștiguri

Adobe Raises FY25 Rev and EPS Targets

12 iun. 2025, 20:05 UTC

Câștiguri

Adobe Sees FY Adj EPS $20.50-Adj EPS $20.70 >ADBE

12 iun. 2025, 20:05 UTC

Câștiguri

Adobe 2Q Digital Experience Revenue $1.46B >ADBE

12 iun. 2025, 20:05 UTC

Câștiguri

Adobe 2Q Digital Media Revenue $4.35B >ADBE

12 iun. 2025, 20:05 UTC

Câștiguri

Adobe Sees 3Q EPS $4.00-EPS $4.05 >ADBE

12 iun. 2025, 20:05 UTC

Câștiguri

Adobe 2Q Net $1.69B >ADBE

12 iun. 2025, 20:05 UTC

Câștiguri

Adobe 2Q EPS $3.94 >ADBE

12 iun. 2025, 20:05 UTC

Câștiguri

Adobe 2Q Digital Experience Revenue Up 10% >ADBE

12 iun. 2025, 20:05 UTC

Câștiguri

Adobe 2Q Rev $5.87B >ADBE

12 iun. 2025, 20:05 UTC

Câștiguri

Adobe Sees 3Q Adj EPS $5.15-Adj EPS $5.20 >ADBE

12 iun. 2025, 20:05 UTC

Câștiguri

Adobe Sees FY EPS $16.30-EPS $16.50 >ADBE

12 iun. 2025, 20:05 UTC

Câștiguri

Adobe 2Q Digital Media Revenue Up 11% >ADBE

12 iun. 2025, 20:05 UTC

Câștiguri

Adobe 2Q Adj EPS $5.06 >ADBE

Comparație

Modificare preț

Avita Therapeutics Inc Așteptări

Obiectiv de preț

By TipRanks

161.55% sus

Prognoză pe 12 luni

Medie 15.17 USD  161.55%

Maxim 19 USD

Minim 12.5 USD

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAvita Therapeutics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

3 ratings

3

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

8.83 / 9.77Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Bullish Evidence

Termen lung

Weak Bearish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.